KRW 12520.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 30.25 Billion KRW | -51.07% |
2022 | 61 Billion KRW | -33.39% |
2021 | 91.58 Billion KRW | -16.01% |
2020 | 109.05 Billion KRW | 47.39% |
2019 | 73.99 Billion KRW | 26.4% |
2018 | 58.53 Billion KRW | 20.03% |
2017 | 48.76 Billion KRW | 34.69% |
2016 | 36.2 Billion KRW | 5.11% |
2015 | 34.44 Billion KRW | 3869.06% |
2014 | -913.96 Million KRW | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 7.74 Billion KRW | -18.15% |
2024 Q1 | 9.52 Billion KRW | 156.54% |
2023 FY | 29.85 Billion KRW | -51.07% |
2023 Q1 | 9.55 Billion KRW | 10.44% |
2023 Q2 | 9.9 Billion KRW | 3.65% |
2023 Q3 | 6.67 Billion KRW | -32.61% |
2023 Q4 | 3.71 Billion KRW | -44.4% |
2022 FY | 61 Billion KRW | -33.39% |
2022 Q4 | 8.65 Billion KRW | 74.35% |
2022 Q3 | 4.96 Billion KRW | -76.37% |
2022 Q2 | 21.01 Billion KRW | 15.97% |
2022 Q1 | 18.11 Billion KRW | -24.61% |
2021 Q2 | 22.97 Billion KRW | -19.19% |
2021 Q3 | 16.15 Billion KRW | -29.69% |
2021 FY | 91.58 Billion KRW | -16.01% |
2021 Q1 | 28.42 Billion KRW | 7.6% |
2021 Q4 | 24.03 Billion KRW | 48.79% |
2020 FY | 109.05 Billion KRW | 47.39% |
2020 Q4 | 26.42 Billion KRW | 14.24% |
2020 Q3 | 23.12 Billion KRW | -34.84% |
2020 Q2 | 35.48 Billion KRW | 47.14% |
2020 Q1 | 24.12 Billion KRW | 20.05% |
2019 Q2 | 19.82 Billion KRW | 18.61% |
2019 Q1 | 16.71 Billion KRW | 0.56% |
2019 FY | 73.99 Billion KRW | 26.4% |
2019 Q4 | 20.09 Billion KRW | 15.15% |
2019 Q3 | 17.44 Billion KRW | -11.97% |
2018 Q2 | 13.72 Billion KRW | -5.35% |
2018 Q1 | 14.5 Billion KRW | 12.25% |
2018 Q3 | 13.69 Billion KRW | -0.22% |
2018 FY | 58.53 Billion KRW | 20.03% |
2018 Q4 | 16.61 Billion KRW | 21.36% |
2017 FY | 48.76 Billion KRW | 34.69% |
2017 Q2 | 11.97 Billion KRW | 14.24% |
2017 Q1 | 10.48 Billion KRW | 22.39% |
2017 Q4 | 12.91 Billion KRW | -3.52% |
2017 Q3 | 13.38 Billion KRW | 11.79% |
2016 Q2 | 10.27 Billion KRW | 8.79% |
2016 FY | 36.2 Billion KRW | 5.11% |
2016 Q4 | 8.56 Billion KRW | 8.0% |
2016 Q3 | 7.93 Billion KRW | -22.77% |
2016 Q1 | 9.44 Billion KRW | 22.64% |
2015 Q4 | 7.69 Billion KRW | -23.18% |
2015 Q3 | 10.02 Billion KRW | 10.88% |
2015 Q2 | 9.03 Billion KRW | 17.49% |
2015 Q1 | 7.69 Billion KRW | 0.0% |
2015 FY | 34.44 Billion KRW | 3869.06% |
2014 FY | -913.96 Million KRW | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
NeoPharm CO., LTD. | 25.3 Billion KRW | -19.554% |